Last updated on March 2019

A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Find a site near you

Start Over

Levine Cancer Institute

Charlotte, NC United States
  Connect »

West Virginia University

Morgantown, WV United States
  Connect »

University of Colorado

Aurora, CO United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Stanford Hospitals and Clinics

Palo Alto, CA United States
  Connect »

Huntsman Cancer institute

Salt Lake City, UT United States
  Connect »

University of Alabama

Birmingham, AL United States
  Connect »


San Francisco, CA United States
  Connect »

Georgia Cancer Specialists

Decatur, GA United States
  Connect »

University of Iowa Healthcare

Iowa City, IA United States
  Connect »

University of Michigan

Ann Arbor, MI United States
  Connect »

Atlantic Health

Morristown, NJ United States
  Connect »

The Christ Hospital

Cincinnati, OH United States
  Connect »

The Tweed Hospital

Tweed Heads, Australia
  Connect »

Christchurch Hospital

Christchurch, New Zealand
  Connect »

Waikato Hospital

Hamilton, New Zealand
  Connect »

Liverpool Hospital

Westmead, Australia
  Connect »

Melanoma Institute

Wollstonecraft, Australia
  Connect »

Adelaide Cancer Centre

Kurralta Park, Australia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.